Monthly archive | PharmaTutor

4 January 2020

Recruitment for Pharmacists at Hindustan Aeronautics Ltd

Hindustan Aeronautics Ltd (HAL), a Navratna Central Public Sector Undertaking, is a premier Aeronautical Industry of South East Asia, with 20 Production/Overhaul/ Service Divisions and 10 co-located R&D Centers spread across the Country. HAL’s spectrum of expertise encompasses design, development, manufacture, repair, overhaul and upgrade of Aircraft, Helicopters, Aero-engines, Industrial & Marine Gas Turbines, Accessories, Avionics & Systems and structural components for Satellites & Launch Vehicles.

Post : Pharmacist

4 January 2020

Recruitment for Pharmacists at ECHS Cell, Rajasthan

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

Post : Pharmacist

Read more about Using gene therapy to treat chronic traumatic encephalopathy

A new study shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy (CTE). The study, which demonstrated the effectiveness of direct delivery of gene therapy into the brain of a mouse model of CTE, is published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Read more about Daratumumab involved in risk of reactivation of hepatitis B virus

The Medicines and Healthcare Products Regulatory Agency (MHRA) London has announced that the product information for daratumumab will be updated to include the risk of reactivation of hepatitis B virus (HBV).

Read more about Vildagliptin

Risk of hepatotoxicity

New Zealand. Medsafe has announced that hepatotoxicity is the most significant risk of harm with vildagliptin.

Vildagliptin is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes.

Read more about Tramadol

Possible risk of opioid effects in breastfed babies

New Zealand. Medsafe has announced that CARM received a case report where a neonate suffered feeding disorder, somnolence (sleepiness), respiratory disorder and weight decrease while the breastfeeding mother was taking tramadol (Tramal® and Arrow®).

Read more about Tocilizumab

Rare risk of hepatic injury

Ireland. The HPRA has announced that serious cases of drug-induced liver injury, (such as acute liver failure, hepatitis and jaundice and cases requiring liver transplantation) have been observed in patients treated with tocilizumab (RoActemra®).

Read more about Paracetamol

Dangerous when not used correctly

New Zealand. Medsafe has announced that they have received cases of serious adverse events related to medication errors associated with prescribing, dispensing and communication to caregivers in children.